Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial.
Baker JV, Sharma S, Grund B, Rupert A, Metcalf JA, Schechter M, Munderi P, Aho I, Emery S, Babiker A, Phillips A, Lundgren JD, Neaton JD, Lane HC; INSIGHT START (Strategic Timing of AntiRetroviral Treatment) Study Group.
Baker JV, et al. Among authors: rupert a.
Open Forum Infect Dis. 2017 Nov 28;4(4):ofx262. doi: 10.1093/ofid/ofx262. eCollection 2017 Fall.
Open Forum Infect Dis. 2017.
PMID: 29308409
Free PMC article.